| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 795377 | 65845 | CARVEDILOL KRKA 6,25 MG COMPRIMIDOS EFG | CARVEDILOL KRKA 6,25 MG COMPRIMIDOS EFG , 28 comprimidos | 6,25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65845/65845_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65845/65845_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1575 | KRKA FARMACEUTICA S.L. | 2004-01-12 | 1 | 1 | 1 | 2004-01-12 | 2004-01-12 | 1 | 2011-11-15 | View Edit Delete | ||||||||||||
| 664584 | 62107 | CISPLATINO PHARMACIA 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO PHARMACIA 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 50 ml | 1 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62107/62107_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62107/62107_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15826 | PFIZER S.L. | 1998-06-01 | 1 | 1 | 1 | 1998-06-01 | 2010-01-14 | 1 | 2011-03-01 | View Edit Delete | ||||||||||||
| 664585 | 62107 | CISPLATINO PHARMACIA 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CISPLATINO PHARMACIA 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 100 ml | 1 mg/ml inyectable 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62107/62107_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62107/62107_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15826 | PFIZER S.L. | 1998-06-01 | 1 | 1 | 1 | 1998-06-01 | 2010-01-14 | 1 | 2011-03-01 | View Edit Delete | ||||||||||||
| 664731 | 62123 | CARBOPLATINO PHARMACIA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARBOPLATINO PHARMACIA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 ml | 10 mg/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62123/62123_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62123/62123_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15826 | PFIZER S.L. | 1998-06-01 | 1 | 1 | 1 | 1998-06-01 | 2010-02-02 | 0 | 2011-03-01 | View Edit Delete | ||||||||||||
| 664732 | 62123 | CARBOPLATINO PHARMACIA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARBOPLATINO PHARMACIA 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 45 ml | 10 mg/ml inyectable 45 ml | 45 | 1 | 34 | 1 vial de 45 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62123/62123_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62123/62123_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 15826 | PFIZER S.L. | 1998-06-01 | 1 | 1 | 1 | 1998-06-01 | 2010-02-02 | 0 | 2011-03-01 | View Edit Delete | ||||||||||||
| 603003 | 69910 | EPTADONE 5 mg/ml SOLUCION ORAL | EPTADONE 5 mg/ml SOLUCION ORAL, 1 frasco de 1.000 ml | 5 mg/ml | 6 | 1000 | 26 | 1 frasco de 1.000 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69910/69910_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69910/69910_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2008-06-24 | 1 | 1 | 1 | 2008-06-24 | 2008-06-24 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 606682 | 79376 | LEVOMETADONA MOLTENI 5 MG/ML SOLUCION ORAL | LEVOMETADONA MOLTENI 5 MG/ML SOLUCION ORAL , 500 ml | 5 mg/ml | 6 | 500 | 26 | 500 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/79376/79376_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/79376/79376_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2015-09-17 | 1 | 1 | 1 | 2015-09-17 | 2015-10-06 | 1 | 2019-05-29 | Lista I | View Edit Delete | |||||||||||
| 661163 | 69909 | EPTADONE 100 mg SOLUCION ORAL | EPTADONE 100 mg SOLUCION ORAL, 1 frasco unidosis de 20 ml | 100 mg | 6 | 1 | 17 | 1 frasco unidosis de 20 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69909/69909_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69909/69909_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2008-06-24 | 1 | 1 | 1 | 2008-06-24 | 2008-06-24 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 661167 | 69913 | EPTADONE 20 mg SOLUCION ORAL | EPTADONE 20 mg SOLUCION ORAL, 1 frasco unidosis de 20 ml | 20 mg | 6 | 1 | 17 | 1 frasco unidosis de 20 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69913/69913_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69913/69913_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1585 | LABORATORIOS GEBRO PHARMA S.A. | 2008-06-24 | 1 | 1 | 1 | 2008-06-24 | 2008-06-24 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 820860 | 62040 | ORAMORPH 20 MG/ML SOLUCION ORAL | ORAMORPH 20 MG/ML SOLUCION ORAL, 1 frasco de 20 ml | 20 mg/ml | 6 | 20 | 26 | 1 frasco de 20 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62040/62040_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62040/62040_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1585 | GRÜNENTHAL PHARMA S.A. | 2003-06-17 | 1 | 1 | 1 | 2003-06-17 | 2003-06-17 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 821934 | 62039 | ORAMORPH 2 MG/ML SOLUCION ORAL | ORAMORPH 2 MG/ML SOLUCION ORAL , 1 frasco de 100 ml | 2 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62039/62039_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62039/62039_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1585 | GRÜNENTHAL PHARMA S.A. | 2003-06-26 | 1 | 1 | 1 | 2003-06-26 | 2003-06-26 | 1 | 2011-10-10 | Lista I | View Edit Delete | |||||||||||
| 728067 | 00150010IP | ACTOS 30 MG COMPRIMIDOS | ACTOS 30 MG COMPRIMIDOS, 56 comprimidos | 30 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00150010IP/00150010IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00150010IP/00150010IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15979 | ELAM PHARMA LABS S.L. | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2020-10-27 | View Edit Delete | ||||||||||||
| 728068 | 00150004IP | ACTOS 30 mg COMPRIMIDOS | ACTOS 30 mg COMPRIMIDOS, 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/00150004IP/00150004IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/00150004IP/00150004IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15979 | ELAM PHARMA LABS S.L. | 2020-02-25 | 1 | 1 | 1 | 2020-02-26 | 2020-02-25 | 1 | 2020-10-27 | View Edit Delete | ||||||||||||
| 770218 | 689730000 | LETROZOL STADA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LETROZOL STADA 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 2,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/689730000/689730000_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1598 | MELYFARMA S.L. | 2026-03-31 | 1 | 1 | 1 | 2026-04-01 | 2026-03-31 | 1 | 2026-05-12 | View Edit Delete | ||||||||||||
| 607501 | 86916 | TRABECTEDINA TEVA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | TRABECTEDINA TEVA 0,25 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial | 0,25 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86916/86916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86916/86916_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2022-04-21 | 1 | 1 | 1 | 2022-04-22 | 2022-04-21 | 1 | 2022-09-14 | View Edit Delete | ||||||||||||
| 651152 | 04304004 | AZILECT 1 MG COMPRIMIDOS | AZILECT 1 MG COMPRIMIDOS, 30 comprimidos | 1 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/04304004/04304004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/04304004/04304004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 2005-06-16 | 1 | 1 | 1 | 2005-06-16 | 2005-06-16 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 661488 | 62012 | MEGEFREN SOBRES | MEGEFREN SOBRES, 30 sobres | 160 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62012/62012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62012/62012_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA PHARMA S.L.U. | 1998-07-01 | 1 | 1 | 1 | 1998-07-01 | 1998-07-01 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 664629 | 09584003 | SILDENAFILO TEVA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SILDENAFILO TEVA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos | 25 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09584003/09584003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09584003/09584003_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA GENERICOS ESPAÑOLA S.L. | 2010-02-05 | 1 | 1 | 1 | 2010-02-05 | 2010-02-05 | 1 | 2013-06-23 | View Edit Delete | ||||||||||||
| 664630 | 09584009 | SILDENAFILO TEVA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SILDENAFILO TEVA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 4 comprimidos | 50 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09584009/09584009_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09584009/09584009_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA GENERICOS ESPAÑOLA S.L. | 2010-02-05 | 1 | 1 | 1 | 2010-02-05 | 2010-02-05 | 1 | 2011-10-24 | View Edit Delete | ||||||||||||
| 664632 | 09584010 | SILDENAFILO TEVA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | SILDENAFILO TEVA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 8 comprimidos | 50 mg | 5 | 8 | 10 | 8 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/09584010/09584010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/09584010/09584010_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16041 | TEVA GENERICOS ESPAÑOLA S.L. | 2010-02-05 | 1 | 1 | 1 | 2010-02-05 | 2010-02-05 | 1 | 2011-10-24 | View Edit Delete |
Page 210 of 1036, showing 20 records out of 20704 total, starting on record 4181, ending on 4200